↓ Skip to main content

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Overview of attention for article published in Breast Cancer Research, March 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
155 Dimensions

Readers on

mendeley
117 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Published in
Breast Cancer Research, March 2011
DOI 10.1186/bcr2833
Pubmed ID
Authors

Cesar G Sanchez, Cynthia X Ma, Robert J Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Li Lin, Matthew J Ellis

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 1 <1%
Australia 1 <1%
Unknown 113 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 29 25%
Student > Ph. D. Student 25 21%
Student > Master 15 13%
Student > Bachelor 8 7%
Professor > Associate Professor 7 6%
Other 24 21%
Unknown 9 8%
Readers by discipline Count As %
Agricultural and Biological Sciences 42 36%
Medicine and Dentistry 33 28%
Biochemistry, Genetics and Molecular Biology 16 14%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Immunology and Microbiology 2 2%
Other 8 7%
Unknown 13 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2022.
All research outputs
#4,238,000
of 20,947,122 outputs
Outputs from Breast Cancer Research
#552
of 1,839 outputs
Outputs of similar age
#66,906
of 279,175 outputs
Outputs of similar age from Breast Cancer Research
#7
of 15 outputs
Altmetric has tracked 20,947,122 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,839 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,175 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.